(IYH) U.S. Healthcare - Overview
ETF Category: Health | Exchange: NYSE ARCA (USA) | Market Cap: 2.900m USD | Total Return: 14.8% in 12m
Pharmaceuticals, Biotechnology, Medical Devices, Healthcare Services
Total Rating 40
Safety 79
Buy Signal 0.11
Health
Category Rotation: +13.8
TER: 0.40%
TER: 0.40%
AUM:
2.90B
Avg Turnover: 25.1M
Avg Turnover: 25.1M
Risk 3d forecast
Volatility12.7%
VaR 5th Pctl2.25%
VaR vs Median-1.52%
Reward TTM
Sharpe Ratio0.73
Rel. Str. IBD34.5
Rel. Str. Peer Group39.3
Character TTM
Beta0.391
Beta Downside0.427
Hurst Exponent0.478
Drawdowns 3y
Max DD17.91%
CAGR/Max DD0.36
CAGR/Mean DD1.17
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Description: IYH U.S. Healthcare
The iShares U.S. Healthcare ETF (IYH) tracks the investment results of an index composed of U.S. equities within the healthcare sector. The fund maintains a non-diversified structure and commits at least 80% of its assets to securities found in its underlying index.
The healthcare sector typically includes pharmaceutical companies, medical device manufacturers, and healthcare service providers. These businesses often operate under high regulatory oversight and rely on long-term research and development cycles to maintain competitive advantages.
Investors can further examine individual holding valuations and fundamental metrics on ValueRay.
- Medicare reimbursement rate changes impact profitability of managed care holdings
- FDA drug approval cycles dictate clinical stage biotechnology company valuations
- Federal antitrust scrutiny limits consolidation activity among major pharmaceutical players
- Rising R&D expenditures compress operating margins across the life sciences sector
- Aging domestic demographics drive sustained demand for healthcare services and medical devices
What is the price of IYH shares?
As of May 22, 2026, the stock is trading at USD 62.29 with a total of 208,257 shares traded.
Over the past week, the price has changed by +1.01%, over one month by +1.38%, over three months by -5.61% and over the past year by +14.80%.
Over the past week, the price has changed by +1.01%, over one month by +1.38%, over three months by -5.61% and over the past year by +14.80%.
Is IYH a buy, sell or hold?
U.S. Healthcare has no consensus analysts rating.
What are the forecasts/targets for the IYH price?
| Analysts Target Price | - | - |